A detailed history of Fortitude Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 10,350 shares of ABBV stock, worth $1.76 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
10,350
Previous 10,259 0.89%
Holding current value
$1.76 Million
Previous $2.03 Billion 9.22%
% of portfolio
0.66%
Previous 0.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 08, 2025

BUY
$164.99 - $203.87 $15,014 - $18,552
91 Added 0.89%
10,350 $1.84 Billion
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $1.01 Million - $1.23 Million
6,162 Added 150.4%
10,259 $2.03 Billion
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $365,923 - $427,316
2,364 Added 136.41%
4,097 $703 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $238,460 - $268,563
1,733 New
1,733 $269 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.